Robust Data At Primary News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Robust Data At Primary. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Robust Data At Primary Today - Breaking & Trending Today

Frontline Camrelizumab/Rivoceranib Combination Shows Promise in Unresectable HCC

Published: January 18, 2024

Amit Mahipal, MD, discusses data on camrelizumab plus rivoceranib in advanced hepatocellular carcinoma as well as the phase 3 CARES-310 trial, which is currently enrolling patients to receive the combination.

Source: onclive.com

Related Topics:

United StatesComunidad Autonoma De CatalunaAmit MahipalDevelopmental Therapeutics ProgramUniversity Hospitals Seidman Cancer CenterCase Comprehensive Cancer CenterBarcelona Clinic Liver CancerRobust Data At PrimaryClin Cancer